Literature DB >> 23949146

Industry progress report on neuro-oncology: Biotech update 2013.

Malte Ottenhausen1, Imithri Bodhinayake, Matei Banu, Kartik Kesavabhotla, Ashley Ray, John A Boockvar.   

Abstract

For the second time, The Brain Tumor Center of the Weill Cornell Brain and Spine Center, in collaboration with Voices Against Brain Cancer, hosted The Brain Tumor Biotech Summit in New York City in June 2013. After a very successful first summit in 2012, this innovative event has established a platform for intensive networking between neuro-oncologists, neurosurgeons, neuroscientists, members of the biotechnology and pharmaceutical communities, members of the financial community and leaders of non-profit organizations. This year's summit highlighted dendritic cell vaccines, novel antibody, heat shock protein and targeted therapies as well as exosome technologies, MRI-guided therapies and other novel drug delivery tools. This report presents a short overview of the current progress in brain tumor research and therapy as presented at the 2013 Brain Tumor Biotech Summit.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23949146     DOI： 10.1007/s11060-013-1222-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  39 in total

1.  MR-guided focused ultrasound: enhancement of intratumoral uptake of [³H]-docetaxel in vivo.

Authors:  Lili Chen; Zhaomei Mu; Paul Hachem; C-M Ma; Annie Wallentine; Alan Pollack
Journal:  Phys Med Biol       Date:  2010-11-19       Impact factor: 3.609

Review 2.  Heat shock protein-peptide complex in the treatment of glioblastoma.

Authors:  Alfred P See; Gustavo Pradilla; Isaac Yang; Seunggu Han; Andrew T Parsa; Michael Lim
Journal:  Expert Rev Vaccines       Date:  2011-06       Impact factor: 5.217

3.  CD91: a receptor for heat shock protein gp96.

Authors:  R J Binder; D K Han; P K Srivastava
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  Clinical 24 month experience of the first MRgFUS unit for treatment of uterine fibroids in Australia.

Authors:  Andrew Dobrotwir; Emma Pun
Journal:  J Med Imaging Radiat Oncol       Date:  2012-04-24       Impact factor: 1.735

5.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

6.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Authors:  Teri N Kreisl; Lyndon Kim; Kraig Moore; Paul Duic; Cheryl Royce; Irene Stroud; Nancy Garren; Megan Mackey; John A Butman; Kevin Camphausen; John Park; Paul S Albert; Howard A Fine
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

Review 7.  DCVax-Brain and DC vaccines in the treatment of GBM.

Authors:  Christopher J Wheeler; Keith L Black
Journal:  Expert Opin Investig Drugs       Date:  2009-04       Impact factor: 6.206

8.  Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model.

Authors:  Zvi R Cohen; Jacob Zaubermann; Sagi Harnof; Yael Mardor; Dvora Nass; Eyal Zadicario; Arik Hananel; David Castel; Meir Faibel; Zvi Ram
Journal:  Neurosurgery       Date:  2007-04       Impact factor: 4.654

9.  Magnetic Resonance-guided Focused Ultrasound Treatment for Uterine Fibroids: First Study in Indian Women.

Authors:  Shrinivas B Desai; Abhijit A Patil; Rahul Nikam; Ajinkya S Desai; Vrushali Bachhav
Journal:  J Clin Imaging Sci       Date:  2012-12-04

10.  Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Authors:  Surasak Phuphanich; Christopher J Wheeler; Jeremy D Rudnick; Mia Mazer; Hongqian Wang; Miriam A Nuño; Jaime E Richardson; Xuemo Fan; Jianfei Ji; Ray M Chu; James G Bender; Elma S Hawkins; Chirag G Patil; Keith L Black; John S Yu
Journal:  Cancer Immunol Immunother       Date:  2012-07-31       Impact factor: 6.968
View more
  2 in total

1.  Multi-Wavelength Photoacoustic Visualization of High Intensity Focused Ultrasound Lesions.

Authors:  J P Gray; N Dana; K L Dextraze; F Maier; S Emelianov; R R Bouchard
Journal:  Ultrason Imaging       Date:  2015-07-05       Impact factor: 1.578

Review 2.  Neuro-oncology biotech industry progress report.

Authors:  Shamik Chakraborty; Imithri Bodhinayake; Amrit Chiluwal; David J Langer; Rosamaria Ruggieri; Marc Symons; John A Boockvar
Journal:  J Neurooncol       Date:  2016-02-20       Impact factor: 4.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.